The global vitamin B-complex ingredients market size is calculated at USD 3.49 billion in 2025 and is forecasted to reach around USD 5.01 billion by 2034, accelerating at a CAGR of 4.11% from 2025 to 2034. The North America market size surpassed USD 1.17 billion in 2024 and is expanding at a CAGR of 4.29% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Vitamin B-Complex Ingredients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Vitamin B-Complex Ingredients Market Revenue and Volume, by Vitamin Type
8.1.1 Vitamin B1 (Thiamine)
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Vitamin B2 (Riboflavin)
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Vitamin B3 (Niacin/Niacinamide)
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Vitamin B5 (Pantothenic Acid)
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Vitamin B6 (Pyridoxine/Pyridoxal)
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Vitamin B7 (Biotin)
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Vitamin B9 (Folate/Folic Acid)
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Vitamin B12 (Cobalamin)
8.1.8.1. Market Revenue and Volume Forecast
8.1.9. Others
8.1.9.1. Market Revenue and Volume Forecast
9.1. Vitamin B-Complex Ingredients Market Revenue and Volume, by Formulation Type
9.1.1. Tablets
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Capsules
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Powders
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Liquids & Syrups
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast
10.1. Vitamin B-Complex Ingredients Market Revenue and Volume, by End-Use Industry
10.1.1. Dietary Supplements
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Fortified Foods & Beverages
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Pharmaceuticals
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Functional Foods & Nutraceuticals
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Vitamin Type
11.1.2. Market Revenue and Volume Forecast, by Formulation Type
11.1.3. Market Revenue and Volume Forecast, by End-Use Industry
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Vitamin Type
11.1.4.2. Market Revenue and Volume Forecast, by Formulation Type
11.1.4.3. Market Revenue and Volume Forecast, by End-Use Industry
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Vitamin Type
11.1.5.2. Market Revenue and Volume Forecast, by Formulation Type
11.1.5.3. Market Revenue and Volume Forecast, by End-Use Industry
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Vitamin Type
11.2.2. Market Revenue and Volume Forecast, by Formulation Type
11.2.3. Market Revenue and Volume Forecast, by End-Use Industry
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Vitamin Type
11.2.4.2. Market Revenue and Volume Forecast, by Formulation Type
11.2.4.3. Market Revenue and Volume Forecast, by End-Use Industry
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Vitamin Type
11.2.5.2. Market Revenue and Volume Forecast, by Formulation Type
11.2.5.3. Market Revenue and Volume Forecast, by End-Use Industry
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Vitamin Type
11.2.6.2. Market Revenue and Volume Forecast, by Formulation Type
11.2.6.3. Market Revenue and Volume Forecast, by End-Use Industry
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Vitamin Type
11.2.7.2. Market Revenue and Volume Forecast, by Formulation Type
11.2.7.3. Market Revenue and Volume Forecast, by End-Use Industry
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Vitamin Type
11.3.2. Market Revenue and Volume Forecast, by Formulation Type
11.3.3. Market Revenue and Volume Forecast, by End-Use Industry
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Vitamin Type
11.3.4.2. Market Revenue and Volume Forecast, by Formulation Type
11.3.4.3. Market Revenue and Volume Forecast, by End-Use Industry
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Vitamin Type
11.3.5.2. Market Revenue and Volume Forecast, by Formulation Type
11.3.5.3. Market Revenue and Volume Forecast, by End-Use Industry
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Vitamin Type
11.3.6.2. Market Revenue and Volume Forecast, by Formulation Type
11.3.6.3. Market Revenue and Volume Forecast, by End-Use Industry
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Vitamin Type
11.3.7.2. Market Revenue and Volume Forecast, by Formulation Type
11.3.7.3. Market Revenue and Volume Forecast, by End-Use Industry
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Vitamin Type
11.4.2. Market Revenue and Volume Forecast, by Formulation Type
11.4.3. Market Revenue and Volume Forecast, by End-Use Industry
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Vitamin Type
11.4.4.2. Market Revenue and Volume Forecast, by Formulation Type
11.4.4.3. Market Revenue and Volume Forecast, by End-Use Industry
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Vitamin Type
11.4.5.2. Market Revenue and Volume Forecast, by Formulation Type
11.4.5.3. Market Revenue and Volume Forecast, by End-Use Industry
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Vitamin Type
11.4.6.2. Market Revenue and Volume Forecast, by Formulation Type
11.4.6.3. Market Revenue and Volume Forecast, by End-Use Industry
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Vitamin Type
11.4.7.2. Market Revenue and Volume Forecast, by Formulation Type
11.4.7.3. Market Revenue and Volume Forecast, by End-Use Industry
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Vitamin Type
11.5.2. Market Revenue and Volume Forecast, by Formulation Type
11.5.3. Market Revenue and Volume Forecast, by End-Use Industry
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Vitamin Type
11.5.4.2. Market Revenue and Volume Forecast, by Formulation Type
11.5.4.3. Market Revenue and Volume Forecast, by End-Use Industry
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Vitamin Type
11.5.5.2. Market Revenue and Volume Forecast, by Formulation Type
11.5.5.3. Market Revenue and Volume Forecast, by End-Use Industry
12.1. BASF SE
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. DSM Nutritional Products
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Amway Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Pfizer Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Glanbia Nutritional
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Cargill, Incorporate
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Naturex SA
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Vitablend Nederland B.V.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Alfa Aesar (Thermo Fisher)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Hunan Nutramax Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description